Only one-third of patients seeking emergent or urgent care for gout flares received outpatient follow-up care after their ED visit, according to a study published in JCR: Journal of Clinical Rheumatology. The researchers examined outpatient follow-up rates for gout after ED visits at an academic medical center with three EDs and one urban urgent care clinic. Among 159 patients treated for a gout flare between September 2021 and August 2022, only 35.2% had a follow-up visit for gout within 6 months. Using multivariable logistic regression, the researchers identified several factors significantly associated with increased odds of outpatient follow-up: being married (OR, 2.66; CI, 1.25– 5.68; P=0.01), absence of comorbidities (OR, 3.86; CI, 1.01–14.71; P=0.048), colchicine use during the ED visit or at discharge (OR, 2.67; CI, 1.18–6.02; P=0.02), and older age (OR, 1.44; CI, 1.15–1.82; P=0.002, for each 5-year increase). Given the low proportion of patients receiving follow-up care, the researchers wrote that interventions targeting modifiable factors such as discharge prescribing practices may help improve long-term gout management.